Literature DB >> 17710633

Hemorheological mechanisms in Alzheimer's disease.

Chia-Yu Chang1, Hong-Jen Liang, Sin-Yu Chow, Szu-Ming Chen, Der-Zen Liu.   

Abstract

OBJECTIVE: The aim of the present study was to elucidate the underlying mechanisms responsible for hemorheological abnormalities in elderly patients with Alzheimer's disease (AD). SUBJECTS AND METHODS: Twenty-one patients with AD and twenty-three age-matched healthy controls (CON) were studied. We used a controlled-shear rate rheometer generating various flow fields in vitro for simulating blood flow in vivo. The applied experimental techniques provided valid and quantitative data for the analysis of hemorheological abnormalities associated with AD. Principal blood biochemical parameters and hemorheological parameters, including blood viscosity, erythrocyte deformability, erythrocyte aggregation and oxygen transport efficiency of blood were assessed.
RESULTS: The results show no statistically significant difference in most of the blood biochemical parameters between the AD patients and the CON, except that fibrinogen concentration and mean corpuscular cell volume level of erythrocytes (MCV) were significantly higher in the AD patients. Hemorheological parameters including blood viscosity, plasma viscosity, and blood viscoelasticity in the AD patients were considerably higher than the respective factors in the CON. Owing to the MDA levels of the AD patients being significantly higher than that of the CON, the AD patients also showed a decrease in erythrocyte deformability and an increase in blood flow resistance despite the lack of any significant difference in erythrocyte rigidity. In addition, the erythrocyte aggregation of AD patients was higher than that of the CON and reduced oxygen transport efficiency of blood was observed in the AD patients.
CONCLUSIONS: The hemorheological abnormalities found in AD patients may be explained by the parallel findings of oxidative damage on erythrocyte membranes that could result in a decrease of erythrocyte deformability. Furthermore, the oxidative stress-induced elevation of fibrinogen concentration could lead to accelerated erythrocyte aggregation as a consequence of a rise in blood viscosity and blood viscoelasticity. Taken together, these factors may impair the oxygen transport efficiency of blood in AD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17710633     DOI: 10.1080/10739680701411056

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  13 in total

1.  Age-related defects in erythrocyte 2,3-diphosphoglycerate metabolism in dementia.

Authors:  Yury G Kaminsky; V Prakash Reddy; Ghulam Md Ashraf; Ausaf Ahmad; Valery V Benberin; Elena A Kosenko; Gjumrakch Aliev
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

2.  Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology.

Authors:  Joy G Mohanty; Hem D Shukla; Jefferey D Williamson; Lenore J Launer; Satya Saxena; Joseph M Rifkind
Journal:  Proteome Sci       Date:  2010-03-03       Impact factor: 2.480

3.  Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis.

Authors:  Rebecca Craig-Schapiro; Max Kuhn; Chengjie Xiong; Eve H Pickering; Jingxia Liu; Thomas P Misko; Richard J Perrin; Kelly R Bales; Holly Soares; Anne M Fagan; David M Holtzman
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

Review 4.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

5.  Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.

Authors:  Natalia A Stefanova; Kseniya Yi Maksimova; Ekaterina A Rudnitskaya; Natalia A Muraleva; Nataliya G Kolosova
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

6.  Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.

Authors:  Natalia A Stefanova; Nikita I Ershov; Nataliya G Kolosova
Journal:  Oxid Med Cell Longev       Date:  2019-07-15       Impact factor: 6.543

Review 7.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03

8.  Hemodynamic and neuropathological analysis in rats with aluminum trichloride-induced Alzheimer's disease.

Authors:  Szu-Ming Chen; Chi-Chen Fan; Ming-Shiuan Chiue; Chi Chou; Jyh-Horng Chen; Ruey-Shyang Hseu
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 9.  Erythrocytes as Potential Link between Diabetes and Alzheimer's Disease.

Authors:  Cristiana Carelli-Alinovi; Francesco Misiti
Journal:  Front Aging Neurosci       Date:  2017-08-25       Impact factor: 5.750

Review 10.  The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.

Authors:  Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Amparo Urios; Carmina Montoliu
Journal:  J Clin Med       Date:  2020-01-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.